Evidence map›Paper›PMID 36650297›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2023

Correction to: Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review.

Ume Habiba, Radeyah Waseem, Taha Gul Shaikh, Summaiyya Waseem, Syed Hassan Ahmed, Muhammad Sohaib Asghar

Registry-linked trialAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06928766 (Effects of Eszopiclone and Lemborexant in People With Obstructive Sleep Apnoea), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06928766 phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effects of Eszopiclone and Lemborexant in People With Obstructive Sleep Apnoea (OSA) With a Low Arousal Threshold Who Have Difficulty Maintaining or Falling Asleep (ELOSA): A Double-blind, Placebo-controlled, Randomised, Trial.

TypeinterventionalSponsorFlinders UniversityRan2025 to 2027Enrolled15ConditionsOSA - Obstructive Sleep ApneaArmsEszopiclone 3 mg, Placebo, Lemborexant 10mg
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Ume HabibaDow University of Health Sciences, Karachi, Pakistan.
Radeyah WaseemDow University of Health Sciences, Karachi, Pakistan.
Taha Gul ShaikhDow University of Health Sciences, Karachi, Pakistan.
Summaiyya WaseemDow University of Health Sciences, Karachi, Pakistan.
Syed Hassan AhmedDow University of Health Sciences, Karachi, Pakistan.
Muhammad Sohaib AsgharDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA. sohaib_asghar123@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36650297

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.